Table 1.
Characteristics of 752 Evaluable Patients with cT2N0 Esophageal Cancer.
| 752 cT2N0 Patients | |
|---|---|
| N (%) | |
| Age (Mean ± SD) | 63.8±11.1 |
| Gender | |
| Male | 626(82.2%) |
| Female | 126(16.8%) |
| Race | N=732 |
| Caucasian | 683(93.3%) |
| Black | 31(4.2%) |
| Hispanic | 11(1.5%) |
| Asian | 7(1.0%) |
| Zubrod score | N=736 |
| 0=Normal Activity, no symptoms | 177(24.0%) |
| 1=Symptoms but fully ambulatory | 507(68.9%) |
| 2=Symptoms but in bed <50% time | 34(4.6%) |
| 3=Symptoms but in bed 50-100% time | 15(2.0%) |
| 4=Bedridden | 2(0.3%) |
| 5=Moribund | 1(0.1%) |
| ASA Risk Class | N=743 |
| I-II | 180(24.2%) |
| III | 521(70.1%) |
| IV-V | 42(5.7%) |
| BMI (kg/m2) | N=709 |
| Mean±/SD | 28.1±5.6 |
| CHF | N=670 |
| No | 659(98.4%) |
| Yes | 11(1.6%) |
| CAD | N=673 |
| No | 515(76.5%) |
| Yes | 158(23.5%) |
| PVD | N=670 |
| No | 619(92.4%) |
| Yes | 51(7.6%) |
| Hypertension | N=679 |
| No | 279(41.1%) |
| Yes | 400(58.9%) |
| Prior Thoracic Surgery | N=670 |
| No | 596(89.0%) |
| Yes | 74(11.0%) |
| Preoperative Induction therapy | |
| None | 482(64.1%) |
| Chemotherapy/XRT | 225(29.9%) |
| Chemotherapy only | 32(4.3%) |
| XRT only | 13(1.7%) |